fusidic acid has been researched along with Pseudomonas Infections in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aloufy, AK; Boraei, NA; El-Gowelli, HM; El-Halfawy, OM; El-Khordagui, LK; Said, SS | 1 |
| Dudzevicius, V; Sakalauskas, R; Vitkauskiene, A | 1 |
| Høiby, N; Szaff, M | 1 |
| Bourget, P; Carsin, H; Le Bever, H; Lesne-Hulin, A | 1 |
| Harper, J; Wright, GL | 1 |
| Berezina, EK; Koroleva, VG; Petrova, MA | 1 |
| Eykyn, SJ; Phillips, I | 1 |
1 review(s) available for fusidic acid and Pseudomonas Infections
| Article | Year |
|---|---|
Advances in antibiotics.
Topics: Adult; Anti-Bacterial Agents; Cephaloridine; Enterobacteriaceae Infections; Fusidic Acid; Gentamicins; Humans; Infant; Infections; Lincomycin; Nalidixic Acid; Penicillin Resistance; Penicillins; Pseudomonas Infections; Respiratory Tract Infections; Rifampin; Sulfamethoxazole; Tuberculosis; Urinary Tract Infections | 1969 |
1 trial(s) available for fusidic acid and Pseudomonas Infections
| Article | Year |
|---|---|
[Pharmacokinetics of fusidic acid in patients with seriously infected burns].
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Burns; Escherichia coli Infections; Fusidic Acid; Humans; Metabolic Clearance Rate; Pseudomonas Infections; Staphylococcal Infections | 1999 |
5 other study(ies) available for fusidic acid and Pseudomonas Infections
| Article | Year |
|---|---|
Bioburden-responsive antimicrobial PLGA ultrafine fibers for wound healing.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biocompatible Materials; Biofilms; Cellular Microenvironment; Esterases; Female; Fusidic Acid; Lactic Acid; Nanofibers; Particulate Matter; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Silicones; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Wound Healing; Wound Infection | 2012 |
[The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bronchoalveolar Lavage Fluid; Ceftazidime; Cefuroxime; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fusidic Acid; Gentamicins; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Staphylococcus aureus; Sulbactam; Vancomycin Resistance | 2003 |
Antibiotic treatment of Staphylococcus aureus infection in cystic fibrosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Cystic Fibrosis; Dicloxacillin; Female; Fusidic Acid; Humans; Infant; Male; Oxacillin; Probenecid; Pseudomonas Infections; Rifampin; Staphylococcal Infections | 1982 |
Fusidic acid and lincomycin therapy in staphylococcal infections in cystic fibrosis.
Topics: Adolescent; Bronchopneumonia; Child; Child, Preschool; Chloramphenicol; Cloxacillin; Cystic Fibrosis; Female; Fusidic Acid; Humans; Infant; Lincomycin; Male; Neomycin; Novobiocin; Penicillin Resistance; Penicillin V; Pseudomonas Infections; Staphylococcal Infections; Tetracycline | 1970 |
[Experimental purulent meningitis and its treatment with antibiotics].
Topics: Animals; Anti-Bacterial Agents; Carbenicillin; Fusidic Acid; Injections, Intravenous; Meningitis; Oxacillin; Penicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Thrombophlebitis; Time Factors | 1974 |